August Bioservices is an expert, collaborative, drug discovery, clinical development, and clinical manufacturing company.
August Bioservices has raised $65.0M in total funding. The most recent round was Series B. The last funding was announced in December 2022.
August Bioservices's investors include Oak HC/FT, Polaris Partners.
August Bioservices is headquartered in Nashville, United States.
August Bioservices is an expert, collaborative, drug discovery, clinical development, and clinical manufacturing company.
August Bioservices is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"August Bioservices — Funding & Investors." VCBacked, December 1, 2022, https://www.vcbacked.co/company/august-bioservices. Accessed August 16, 2026.
VCBacked. (2022). August Bioservices — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/august-bioservices
{{cite web |title=August Bioservices — Funding & Investors |url=https://www.vcbacked.co/company/august-bioservices |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated